M. Kok

发表

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.

Maarten J. IJzerman, J. W. Louwerenburg, M. Stoel, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.

Maarten J. IJzerman, C. von Birgelen, G. Linssen, 2017, Journal of cardiology.

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Maarten J. IJzerman, J. W. Louwerenburg, C. von Birgelen, 2016, Heart and Vessels.

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).

Maarten J. IJzerman, M. Stoel, C. von Birgelen, 2016, American heart journal.

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

M. Stoel, C. von Birgelen, G. Linssen, 2018, Journal of the American Heart Association.

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial

C. von Birgelen, G. Linssen, C. Schotborgh, 2018, Cardiovascular Drugs and Therapy.

Involving the patient's perspective and preferences concerning coronary angiography and percutaneous coronary intervention.

C. von Birgelen, Marlies M Kok, M. Kok, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction

R. Peters, C. von Birgelen, Liefke C. van der Heijden, 2018, Heart and vessels.

New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.

M. Stoel, A. Roguin, C. von Birgelen, 2020, American heart journal.

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial

M. Stoel, C. von Birgelen, G. Linssen, 2017, JAMA cardiology.

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

M. Stoel, A. Roguin, C. von Birgelen, 2020, International Journal of Cardiology.

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2018, International journal of cardiology.

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

A. Roguin, C. von Birgelen, G. Linssen, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2018, JACC: Cardiovascular Interventions.

Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis.

M. Beijk, P. Woudstra, J. Tijssen, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

C. von Birgelen, G. Linssen, F. de Man, 2015, American heart journal.

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

M. Stoel, C. von Birgelen, G. Linssen, 2017, Cardiology.

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial

Maarten J. IJzerman, C. von Birgelen, G. Linssen, 2015, Clinical Research in Cardiology.

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

M. Stoel, C. von Birgelen, G. Linssen, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.

M. Stoel, C. von Birgelen, G. Linssen, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Thin, Very Thin, or Ultrathin Strut Biodegradable- or Durable-Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.

M. Stoel, C. von Birgelen, G. Linssen, 2019, JACC. Cardiovascular interventions.

Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial.

M. Stoel, C. von Birgelen, G. Linssen, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

M. Stoel, C. von Birgelen, G. Linssen, 2022, Journal of the American Heart Association.

Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials

C. von Birgelen, M. Weernink, J. V. Van Til, 2018, Health expectations : an international journal of public participation in health care and health policy.